JP2021506275A5 - - Google Patents

Info

Publication number

JP2021506275A5

JP2021506275A5 JP2020532815A JP2020532815A JP2021506275A5 JP 2021506275 A5 JP2021506275 A5 JP 2021506275A5 JP 2020532815 A JP2020532815 A JP 2020532815A JP 2020532815 A JP2020532815 A JP 2020532815A JP 2021506275 A5 JP2021506275 A5 JP 2021506275A5

Authority

JP

Japan

Prior art keywords

tnfr

nucleic acid

chimeric

item

domain

Prior art date

2018-12-14

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 56
• 102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 56
• 150000007523 nucleic acids Chemical class 0.000 claims description 38
• 210000004027 cell Anatomy 0.000 claims description 33
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 24
• 239000013598 vector Substances 0.000 claims description 21
• 230000011664 signaling Effects 0.000 claims description 20
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 18
• 108091008874 T cell receptors Proteins 0.000 claims description 18
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 18
• 108020004707 nucleic acids Proteins 0.000 claims description 11
• 102000039446 nucleic acids Human genes 0.000 claims description 11
• 230000009261 transgenic effect Effects 0.000 claims description 9
• 239000008194 pharmaceutical composition Substances 0.000 claims description 8
• 239000003446 ligand Substances 0.000 claims description 7
• 201000010099 disease Diseases 0.000 claims description 6
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
• 108020001756 ligand binding domains Proteins 0.000 claims description 5
• 102100027207 CD27 antigen Human genes 0.000 claims description 3
• 101150013553 CD40 gene Proteins 0.000 claims description 3
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 3
• 101100046559 Mus musculus Tnfrsf12a gene Proteins 0.000 claims description 3
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• 230000002265 prevention Effects 0.000 claims description 3
• 101150117815 D3R gene Proteins 0.000 claims description 2
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims description 2
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims description 2
• 206010028980 Neoplasm Diseases 0.000 claims description 2
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims description 2
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims description 2
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 2
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 2
• 101100222866 Vaccinia virus (strain Ankara) MVA100R gene Proteins 0.000 claims description 2
• 101100222869 Vaccinia virus (strain Western Reserve) VACWR108 gene Proteins 0.000 claims description 2
• 201000011510 cancer Diseases 0.000 claims description 2
• 230000004913 activation Effects 0.000 claims 1
• 230000019491 signal transduction Effects 0.000 description 7
• 238000000034 method Methods 0.000 description 6
• 239000000427 antigen Substances 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 238000012986 modification Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 102100025221 CD70 antigen Human genes 0.000 description 1
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 1
• -1 RANK Proteins 0.000 description 1
• 230000000735 allogeneic effect Effects 0.000 description 1
• 210000002203 alpha-beta t lymphocyte Anatomy 0.000 description 1
• 230000004186 co-expression Effects 0.000 description 1
• 210000004405 cytokine-induced killer cell Anatomy 0.000 description 1
• 210000004475 gamma-delta t lymphocyte Anatomy 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 230000002463 transducing effect Effects 0.000 description 1